Well, we should get the quarterly tomorrow.ZYL is completely unloved by the market right now, no matter how much the company presents, roadshows etc.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025